
11 - 50 employees
Founded 2024
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jade Biosciences is a clinical-stage biotechnology company developing potentially best-in-class therapies aimed at transforming the standard of care for autoimmune diseases. Its lead candidate, JADE101, is an antibody designed to inhibit the cytokine APRIL (A PRoliferation-Inducing Ligand) and is being developed for the treatment of immunoglobulin A nephropathy (IgAN). The company builds its pipeline from discovery-stage assets licensed from Paragon Therapeutics and is focused on advancing clinical programs to deliver new treatments for patients with autoimmune conditions.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2024
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jade Biosciences is a clinical-stage biotechnology company developing potentially best-in-class therapies aimed at transforming the standard of care for autoimmune diseases. Its lead candidate, JADE101, is an antibody designed to inhibit the cytokine APRIL (A PRoliferation-Inducing Ligand) and is being developed for the treatment of immunoglobulin A nephropathy (IgAN). The company builds its pipeline from discovery-stage assets licensed from Paragon Therapeutics and is focused on advancing clinical programs to deliver new treatments for patients with autoimmune conditions.
• Serve as Head of Pharmacovigilance, accountable for safety strategy, safety science, and PV operations across the portfolio • Report to the Chief Medical Officer • Build a fit-for-purpose, inspection-ready PV function that scales with JADE101 global Phase 3 development and JADE201/JADE301 early development • Establish safety governance and signal management frameworks • Oversee outsourced PV vendors and author or review key safety deliverables • Partner with Clinical Development, Regulatory Affairs, Clinical Operations, Biometrics, Quality, and Program Management • Ensure timely, compliant expedited and periodic reporting, including SUSARs, IND safety reports, and DSURs, to FDA, EMA, and other health authorities • Author or provide senior review of safety content for protocols, Investigator’s Brochures, informed consent forms, clinical study reports, and health authority responses • Support global expansion, including Japanese and Chinese regulatory interactions and multi-region Phase 3 execution • Oversee safety database management, case processing, reconciliation, literature screening, and submissions • Own vendor KPIs, quality metrics, PV budget, and resourcing model • Negotiate and implement safety data exchange agreements with partners, licensors, and CROs • Build and maintain PV quality systems, SOPs, work instructions, training curricula, and PV system master file • Ensure GVP/GCP compliance and lead PV inspection- and audit-readiness activities with Quality Assurance • Identify and close process gaps during transition from early- to late-stage development • Hire, mentor, and develop PV staff and consultants; establish scalable processes and a culture of scientific rigor and accountability
• Bachelor’s degree with 10–15 years of industry experience • Minimum of 10 years of pharmacovigilance/drug safety experience in the biopharmaceutical industry • Progressive leadership responsibility; Executive Director level requires broader scope and prior head-of-function experience • Demonstrated experience as head of PV or deputy in a development-stage company • Experience building fit-for-purpose PV processes and quality systems • Deep working knowledge of global PV regulations and guidance, including 21 CFR, ICH E2A/E2B/E2C/E2D/E2F, and EU GVP modules • Knowledge of expedited and aggregate reporting requirements • Experience selecting and overseeing PV vendors, safety databases such as Argus, and outsourced case processing operations • Experience supporting FDA and/or EMA health authority inspections and client/sponsor audits with successful outcomes • Excellent scientific judgment, written and verbal communication, and cross-functional collaboration skills • Preferred: 10 years of experience with biologics/monoclonal antibodies and immunology, rheumatology, nephrology, or rare disease programs • Preferred: Experience supporting late-stage global development and BLA/MAA safety deliverables, including risk management plans • Preferred: Familiarity with safety data visualization and analytics tools for signal detection • Preferred: Experience integrating PV requirements across licensing/partnering relationships • Preferred: Prior experience scaling a PV function from first-in-human through Phase 3 and toward marketing authorization • Authorization to work in the United States as verified through I-9 and E-Verify
• Remote work arrangement • Periodic travel to team and company events
Apply Now🔥 6 hours ago
Senior director leading global medical-device product portfolio strategy at Fresenius Kabi. Driving lifecycle optimization, investment decisions, governance, and cross-functional growth initiatives.
🔥 6 hours ago
Associate Director leading Clario’s global pricing and proposals team for Digital Physiology. Overseeing bids, Statements of Service, change orders, process improvements, and KPI reporting.
🇺🇸 United States – Remote
💰 Private Equity Round on 2019-10
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🔥 6 hours ago
Analytical CMC leader overseeing development and QC for Iambic Therapeutics’ AI-discovered small-molecule medicines. Guiding methods, stability, regulatory filings, CDMOs, and teams from clinical development through commercialization.
🔥 8 hours ago
Senior Director shaping Iron Mountain’s North American employee benefits strategy. Designing compliant health, retirement, and leave programs across the US, Canada, and Puerto Rico.
🔥 8 hours ago
Statistical Innovation Director advancing innovative clinical trial design and analysis at Amgen, a biotechnology company developing medicines for serious illnesses. Advising drug-development programs, simulations, and regulatory strategy.
🇺🇸 United States – Remote
💵 $223.6k - $302.6k / year
💰 $28.5G Post-IPO Debt on 2022-12
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor